Line Probe Assay [LPA] in DR-TB Diagnosis

As per the Integrated Drug-resistant Tuberculosis (DR-TB) Diagnostic Algorithm:

  • Nucleic Acid Amplification Tests (NAAT) are preferred for the initial detection of Rifampicin (R) resistance
  • Line Probe Assays (LPA) are preferred for the detection of Isoniazid (H), Fluoroquinolones (FQ) and second-line injectable (SLI) drugs resistance.

 

When rifampicin resistance is detected by NAAT (see figure below):

LPA: Principles and Technique

The Line Probe Assay (LPA) is a strip based rapid molecular technique based on polymerase chain reaction (PCR) to detect Mycobacterium tuberculosis and resistance to anti-TB drugs.

 

LPA detects resistance to Rifampicin (R), Isoniazid (H), Fluroquinolones (FQ); (Ofloxacin, Ofx; Levofloxacin, Lfx; Moxifloxacin) and second-line injectable (SLI); (Kanamycin, Km; Amikacin, Am) drugs.

 

Principle of LPA

 

Specific Performance Characteristics of TrueNAT: Analytical Exclusivity [Primer Specificity]

TrueNAT assays are Polymerase Chain Reaction (PCR) tests performed using freeze dried PCR reagents and primers contained in microtubes mixed with eluted DNA (Trueprep device) and amplified on Truelab device.

 

The primers for PCR are designed to amplify ribonucleoside-diphosphate reductase gene - nrdZ gene in Mycobacterium tuberculosis (MTB) genome.

 

Analytical Exclusivity (Primer Specificity) test were done by the manufacturer to determine the specificity of the TrueNAT Assays by:

Subscribe to